Literature DB >> 7815326

5-Hydroxytryptamine2B receptor signaling in rat stomach fundus: role of voltage-dependent calcium channels, intracellular calcium release and protein kinase C.

D A Cox1, M L Cohen.   

Abstract

The rat stomach fundus is enriched with the 5-hydroxytryptamine (5-HT)2B receptor, the newest subtype of the 5-HT2 receptor family to be cloned. Although the 5-HT2A and 5-HT2C receptor subtypes couple to phosphatidylinositol hydrolysis, such a coupling has not been established for the 5-HT2B receptor in tissues. Thus, the purpose of this study was to characterize further the signal transduction mechanism of the 5-HT2B receptor in rat stomach fundus. Nitrendipine (1 microM) inhibited the maximal contraction to 5-HT (1 microM) by approximately 50%. Removal of extracellular calcium did not inhibit 5-HT contraction to a greater extent than that produced by nitrendipine, indicating that calcium influx through voltage-dependent calcium channels was predominantly responsible for the dependence of the 5-HT contraction on extracellular calcium. Depletion of both extracellular calcium and intracellular calcium stores abolished 5-HT contraction. Ryanodine (30 microM), a compound which inhibits calcium release from intracellular stores, significantly inhibited the maximal contraction to carbamylcholine (3 microM). In contrast, ryanodine (30 microM) did not inhibit the maximal contraction to 5-HT (1 microM) in the absence of nitrendipine. However, ryanodine (30 microM) did significantly inhibit the nitrendipine-insensitive 5-HT contraction, suggesting that this component of the contraction was due in part to calcium release from a ryanodine-sensitive store. Bisindolylmaleimide (5 microM), a specific inhibitor of protein kinase C (PKC), inhibited 5-HT contraction in either the absence or presence of nitrendipine, suggesting that activation of PKC is also involved.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7815326

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  An expression screen reveals modulators of class II histone deacetylase phosphorylation.

Authors:  Shurong Chang; Svetlana Bezprozvannaya; Shijie Li; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-27       Impact factor: 11.205

2.  RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist.

Authors:  D W Bonhaus; L A Flippin; R J Greenhouse; S Jaime; C Rocha; M Dawson; K Van Natta; L K Chang; T Pulido-Rios; A Webber; E Leung; R M Eglen; G R Martin
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

3.  5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells.

Authors:  C Ullmer; H G Boddeke; K Schmuck; H Lübbert
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Protein kinase C{gamma} mediates regulation of proliferation by the serotonin 5-hydroxytryptamine receptor 2B.

Authors:  Mira M Wouters; Jaime L Roeder; Vivek S Tharayil; Jennifer E Stanich; Peter R Strege; Sha Lei; Michael R Bardsley; Tamas Ordog; Simon J Gibbons; Gianrico Farrugia
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

5.  Localised calcium release events in cells from the muscle of guinea-pig gastric fundus.

Authors:  S P Parsons; T B Bolton
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182

6.  Arterial expression of 5-HT2B and 5-HT1B receptors during development of DOCA-salt hypertension.

Authors:  Amy K L Banes; Stephanie W Watts
Journal:  BMC Pharmacol       Date:  2003-09-15

7.  Computational Methods for the Identification of Molecular Targets of Toxic Food Additives. Butylated Hydroxytoluene as a Case Study.

Authors:  Valentina Tortosa; Valentina Pietropaolo; Valentina Brandi; Gabriele Macari; Andrea Pasquadibisceglie; Fabio Polticelli
Journal:  Molecules       Date:  2020-05-09       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.